TrialJAMA psychiatry2015

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.

Kenneth L Subotnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.